ArticleMicrobial genomics2020
Population structure of KPC carbapenemase-producing
Article in Microbial genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 25 citations in OpenAlex.
- Emergence and Dissemination of NDM+OXA-48-like Co-ProducingAntibiotics (Basel, Switzerland) · 2026Article
- Molecular Characterization of Multidrug-Resistant and Hypervirulent New Delhi Metallo-Beta-LactamaseAntibiotics (Basel, Switzerland) · 2024Article
- Epidemiology, antimicrobial resistance profile and management of carbapenem-resistant Klebsiella pneumoniae among mothers with suspected sepsis in Ethiopia.Annals of clinical microbiology and antimicrobials · 2024Article
- Genomic characterization of colistin-resistant Klebsiella pneumoniae isolated from intensive care unit patients in Egypt.Annals of clinical microbiology and antimicrobials · 2023Article
- Global spread and evolutionary convergence of multidrug-resistant and hypervirulentPathogens and global health · 2023Review
- Rapid quantitative detection ofFrontiers in bioengineering and biotechnology · 2023Article
- Genomic Epidemiology of Carbapenemase-producing Klebsiella pneumoniae in China.Genomics, proteomics & bioinformatics · 2022Article
- Prevalence and Molecular Typing of Carbapenemase-Producing Enterobacterales among Newborn Patients in Italy.Antibiotics (Basel, Switzerland) · 2022Article
- Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022Article
- Resistance and virulence features of hypermucoviscousFrontiers in microbiology · 2022Article
- Whole-Genome Sequencing (WGS) of Carbapenem-ResistantMicroorganisms · 2021Article
- Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2021Article
- A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex.Nature communications · 2021Article
- Mutations in two component system (PhoPQ and PmrAB) in colistin resistant Klebsiella pneumoniae from North Indian tertiary care hospital.The Journal of antibiotics · 2021Article
- Wastewaters, with or without Hospital Contribution, Harbour MDR, Carbapenemase-Producing, but Not HypervirulentAntibiotics (Basel, Switzerland) · 2021Article
- A Recombinase Aided Amplification Assay for Rapid Detection of theFrontiers in cellular and infection microbiology · 2021Article
- Ceftazidime-Avibactam Resistance Associated with IncreasedAntimicrobial agents and chemotherapy · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, we used a whole-genome sequencing (WGS) approach to study the features of KPC-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.